[go: up one dir, main page]

Fronticelli et al., 2005 - Google Patents

Design, Conformational, Functional and Physiological Characterization of Recombinant Polymeric Heme-Proteins

Fronticelli et al., 2005

Document ID
2805698830860626181
Author
Fronticelli C
Brinigar W
Dull R
Koehler R
Publication year
Publication venue
Blood Substitutes

External Links

Snippet

Genetic engineering offers the opportunity to design and construct various mutant hemoglobins possessing conformational and functional characteristics that render them suitable for use as therapeutic agents in a variety of clinical situations. Although it may not …
Continue reading at books.google.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/41—Porphyrin- or corrin-ring-containing peptides
    • A61K38/42—Haemoglobins; Myoglobins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender

Similar Documents

Publication Publication Date Title
US5194590A (en) Acellular red blood cell substitute
US5464814A (en) Acellular red blood cell substitute
US4826811A (en) Acellular red blood cell substitute
Abassi et al. Effects of polymerization on the hypertensive action of diaspirin cross-linked hemoglobin in rats
Alayash et al. Hemoglobin and free radicals: implications for the development of a safe blood substitute
Chang Blood substitutes based on modified hemoglobin prepared by encapsulation or crosslinking: An overview
EP0775157B1 (en) Human serum albumin-porphyrin complexes with the ability to bind oxygen and therapeutic uses thereof
US6114505A (en) Hemoglobin mutants that reduce heme loss
Frietsch et al. Artificial oxygen carriers
IE73248B1 (en) Polyhemoglobin stabilized by purine derivatives and glutathione
Fronticelli et al. Design, Conformational, Functional and Physiological Characterization of Recombinant Polymeric Heme-Proteins
US12180266B2 (en) Modified haemoglobin proteins
US5334705A (en) Benzenetricarboxylate derivative-crosslinked low oxygen affinity hemoglobin
EP0784983A2 (en) Use of extracellular hemoglobin
WO2005041898A2 (en) Blood substitutes
CN101711255A (en) Modified globin proteins with altered electron transport pathway
FI106362B (en) Process for the preparation of a composition, suitable for use as blood substitute
US6812207B1 (en) Hemoglobin mutants that reduce heme loss
Dong et al. Blood Substitutes: What They Are and How They Might Be Used
Friedman et al. Hemoglobin solutions as blood substitutes
Winslow Hemoglobin modification
AU715073C (en) Hemoglobin mutants that reduce heme loss
AU722301B2 (en) Use of hemoglobin to prevent sepsis or treat systemic inflammatory response syndrome
Moore Emerging role of hemoglobin solutions in trauma care
Zhang Development and functional properties of intramolecular crosslinked hemoglobin